AcouSort AB
4SA
Company Profile
Business description
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products include AcouTrap, AcouWash, and AcouPlasma.
Contact
Medicon Village
Building 406
LundSE-223 81
SWET: +46 4520450854
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
16
Stocks News & Analysis
stocks
Avoid this overpriced ASX share
This ASX share is 84% overvalued and lacks a sustainable competitive advantage.
stocks
Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm
A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.
stocks
Baidu: Moat downgraded to none from wide; AI segment growth to offset search decline in long \run
We’ve also lowered our fair value estimate of Baidu stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,924.20 | 83.70 | 0.95% |
| CAC 40 | 8,057.36 | 142.00 | 1.79% |
| DAX 40 | 23,829.75 | 420.38 | 1.80% |
| Dow JONES (US) | 47,757.46 | 16.66 | 0.03% |
| FTSE 100 | 10,376.35 | 126.83 | 1.24% |
| HKSE | 25,959.90 | 202.61 | 0.79% |
| NASDAQ | 22,698.38 | 2.43 | 0.01% |
| Nikkei 225 | 54,248.39 | 1,372.45 | -2.47% |
| NZX 50 Index | 13,094.37 | 523.52 | -3.84% |
| S&P 500 | 6,786.18 | 9.81 | -0.14% |
| S&P/ASX 200 | 8,692.60 | 90.30 | 1.05% |
| SSE Composite Index | 4,123.14 | 26.54 | 0.65% |